Inventor · disambiguated record
Raymond E. Stevens
Also filed as: STEVENS JR RAYMOND E · STEVENS RAYMOND · STEVENS RAYMOND E
7 granted patents·4 pending applications·38 citations·filing 2014–2023
84Inventor score
Top patents by PatentIndex Score
11 records- 0194US10065922B2Solabegron zwitterion and uses thereofVELICEPT THERAPEUTICS INC·Filed 2016·Granted Sep 4, 2018·9 cites·126 claims
- 0293US10221126B2Solabegron zwitterion and uses thereofVELICEPT THERAPEUTICS INC·Filed 2018·Granted Mar 5, 2019·4 cites·9 claims
- 0390US12435026B2Solabegron zwitterion and uses thereofB3AR THERAPEUTICS INC·Filed 2023·Granted Oct 7, 2025·1 cites·19 claims
- 0490US10844004B2Solabegron zwitterion and uses thereofVELICEPT THERAPEUTICS INC·Filed 2019·Granted Nov 24, 2020·2 cites·13 claims
- 0590US9956194B2Compositions and methods of using modified release solabegron for lower urinary tract symptomsVELICEPT THERAPEUTICS INC·Filed 2015·Granted May 1, 2018·18 cites·60 claims
- 0686US11691944B2Solabegron zwitterion and uses thereofB3AR THERAPEUTICS INC·Filed 2020·Granted Jul 4, 2023·2 cites·19 claims
- 0783US10751311B2Compositions and methods of using modified release solabegron for lower urinary tract symptomsVELICEPT THERAPEUTICS INC·Filed 2018·Granted Aug 25, 2020·2 cites·16 claims
- 0854US2024197660A1Compositions of micronized solabegron and methods of useB3AR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0945US2014322162A1Use of Ferritin to Treat Iron DisordersCHYNA LLC·Filed 2014·Application pending·0 cites
- 1042US2017348288A1Dosing regimens for beta-3 adrenoceptor agonists and anti-muscarinic agents for the treatment and prevention of lower urinary tract symptoms and overactive bladderVELICEPT THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1142US2017348263A1Compositions and methods of using modified release solabegron for lower urinary tract symptomsVELICEPT THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Raymond E. Stevens files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →